News and Activities
Hot Off The Press.
Press Releases
Proteocyte AI featured in online publication 360Dx
Toronto, ON; March 29, 2018 - Proteocyte Diagnostics, a computational pathology company that has built a platform-based technology that predicts your risk of developing cancer, was recently featured in 360Dx. 360Dx covers emerging economic and technological trends in the clinical diagnostic...
Today Proteocyte Diagnostics becomes…
Toronto, ON; March 9, 2018 - Proteocyte Diagnostics, a computational pathology company that has built a platform-based technology that predicts your risk of developing cancer, announced a name change to Proteocyte AI, effectively immediately. “Our new corporate identity better reflects how we...
First Global Meeting for Straticyte™ at the 6th World Oral Cancer Congress a Success
Toronto, ON; June 2, 2017 - Proteocyte Diagnostics hosted their first global Straticyte meeting at the 6th World Oral Cancer Congress of the International Academy of Oral Oncology (IAOO) in India on May 18, 2017. The meeting included leading oral cancer healthcare professionals from around the...
New Study Shows Straticyte™ More Accurate Than Dysplasia Grading
Toronto, ON; February 2, 2017 - A newly published study shows Straticyte better defines the risk for developing oral squamous cell carcinoma than histopathological dysplasia grading alone. The study “Individualized Five-Year Risk Assessment for Oral Pre-malignant Progression to Cancer”was just...